EuBiologics Revenue

In the year 2024, EuBiologics had annual revenue of 96.04B KRW with 38.45% growth. EuBiologics had revenue of 26.89B in the quarter ending December 31, 2023, with 54.38% growth.

Revenue

96.04B

Revenue Growth

+62.39%

P/S Ratio

5.40

Revenue / Employee

n/a

Employees

n/a

Market Cap

518.90B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	96.04B	26.67B	38.45%
Dec 31, 2023	69.37B	13.90B	25.06%
Dec 31, 2022	55.47B	16.08B	40.83%
Dec 31, 2021	39.38B	10.90B	38.24%
Dec 31, 2020	28.49B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Bukwang Pharmaceutical	184.38B
Shinpoong Pharmaceutical Co.,Ltd	231.90B
Dong-A ST	770.63B
FutureChem Co.,Ltd	18.75B
Dong-A Socio Holdings	1,404.83B
Humedix	110.99B
JW Pharmaceutical	764.21B
Huons Global	825.44B

Revenue Rankings